Enhanced antitumor effect of combined replicative adenovirus and nonreplicative adenovirus expressing interleukin-12 in an immunocompetent mouse modelNAGAYAMA, Y; NAKAO, K; MIZUGUCHI, H et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 16, pp 1400-1403, issn 0969-7128, 4 p.Article

Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancertherapyPARKINSON, Richard J; MIAN, Shahid; BISHOP, Michael C et al.The Prostate. 2003, Vol 56, Num 1, pp 65-73, issn 0270-4137, 9 p.Article

Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancerGAO, J.-Q; KANAGAWA, N; OKADA, N et al.Gene therapy (Basingstoke). 2007, Vol 14, Num 6, pp 491-502, issn 0969-7128, 12 p.Article

Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rss₂ or IL-18RαCHOI, I.-K; LEE, J.-S; ZHANG, S.-N et al.Gene therapy (Basingstoke). 2011, Vol 18, Num 9, pp 898-909, issn 0969-7128, 12 p.Article

A study on anti-tumor immunity induced by gene-modified melanoma B16 cellsLIJUAN FANG; KEMIN WANG; XIA LIU et al.Oncology reports. 2008, Vol 19, Num 6, pp 1589-1595, issn 1021-335X, 7 p.Article

Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12YAMANAKA, Ryuya; TSUCHIYA, Naoto; YAJIMA, Naoki et al.Journal of neurosurgery. 2003, Vol 99, Num 4, pp 746-753, issn 0022-3085, 8 p.Article